Literature DB >> 15578755

Tandem mass spectrometric data-FAAH inhibitory activity relationships of some carbamic acid O-aryl esters.

Elisa Basso1, Andrea Duranti, Marco Mor, Daniele Piomelli, Andrea Tontini, Giorgio Tarzia, Pietro Traldi.   

Abstract

We have recently described a class of systemically active inhibitors of the intracellular activity of fatty acid amide hydrolase (FAAH) and traced extensive structure-activity relationships. These compounds, characterized by an N-alkyl carbamic acid O-aryl ester structure, exert potent anxiolytic-like effects in animal models. In the present study, possible relationships between mass spectrometric parameters (related to the propensity of the C(O)--O bond to be cleaved) and FAAH-inhibitory potency were tested. With this aim, a set of our products was analyzed by electrospray ionization mass spectrometry and the protonated molecules were decomposed by low-energy collisions. The experiments were performed by ion trap mass spectrometry, which led to a step-by-step energy deposition, thus favouring the lowest critical energy decomposition channels. For all compounds, breakdown curves relative to [MH](+) ions and to the fragment implying C(O)--O bond cleavage were obtained. The crossing point between these curves was related to the energetics of decomposition and the values found for the investigated compounds were linearly correlated (r(2) = 0.797) with their FAAH-inhibitory activity. This indicates that the energetics of the C(O)--O bond cleavage may be relevant in explaining FAAH inhibition.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15578755     DOI: 10.1002/jms.729

Source DB:  PubMed          Journal:  J Mass Spectrom        ISSN: 1076-5174            Impact factor:   1.982


  7 in total

1.  Mechanism of carbamate inactivation of FAAH: implications for the design of covalent inhibitors and in vivo functional probes for enzymes.

Authors:  Jessica P Alexander; Benjamin F Cravatt
Journal:  Chem Biol       Date:  2005-11

2.  Biphenyl-3-yl alkylcarbamates as fatty acid amide hydrolase (FAAH) inhibitors: steric effects of N-alkyl chain on rat plasma and liver stability.

Authors:  Federica Vacondio; Claudia Silva; Alessio Lodola; Caterina Carmi; Silvia Rivara; Andrea Duranti; Andrea Tontini; Silvano Sanchini; Jason R Clapper; Daniele Piomelli; Giorgio Tarzia; Marco Mor
Journal:  Eur J Med Chem       Date:  2011-07-21       Impact factor: 6.514

3.  Tandem mass spectrometry of nitric oxide and hydrogen sulfide releasing aspirins: a hint into activity behavior.

Authors:  Maria Elisa Crestoni; Barbara Chiavarino; Stefano Guglielmo; Valentina Lilla; Simonetta Fornarini
Journal:  Mass Spectrom (Tokyo)       Date:  2013-04-20

Review 4.  The discovery and development of inhibitors of fatty acid amide hydrolase (FAAH).

Authors:  Katerina Otrubova; Cyrine Ezzili; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2011-06-28       Impact factor: 2.823

5.  Inhibitors of fatty acid amide hydrolase reduce carrageenan-induced hind paw inflammation in pentobarbital-treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors.

Authors:  Sandra Holt; Francesca Comelli; Barbara Costa; Christopher J Fowler
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

6.  Synthesis and quantitative structure-activity relationship of fatty acid amide hydrolase inhibitors: modulation at the N-portion of biphenyl-3-yl alkylcarbamates.

Authors:  Marco Mor; Alessio Lodola; Silvia Rivara; Federica Vacondio; Andrea Duranti; Andrea Tontini; Silvano Sanchini; Giovanni Piersanti; Jason R Clapper; Alvin R King; Giorgio Tarzia; Daniele Piomelli
Journal:  J Med Chem       Date:  2008-05-29       Impact factor: 7.446

7.  Structure-property relationships of a class of carbamate-based fatty acid amide hydrolase (FAAH) inhibitors: chemical and biological stability.

Authors:  Federica Vacondio; Claudia Silva; Alessio Lodola; Alessandro Fioni; Silvia Rivara; Andrea Duranti; Andrea Tontini; Silvano Sanchini; Jason R Clapper; Daniele Piomelli; Marco Mor; Giorgio Tarzia
Journal:  ChemMedChem       Date:  2009-09       Impact factor: 3.466

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.